Gliquidone

From Wikipedia, the free encyclopedia
Gliquidone
Gliquidone.svg
Clinical data
Trade namesGlurenorm
AHFS/Drugs.comInternational Drug Names
Pregnancy
category
  • C
Routes of
administration
Oral (tablets)
ATC code
Legal status
Legal status
  • UK: POM (Prescription only)
  • In general: ℞ (Prescription only)
Pharmacokinetic data
BioavailabilityHigh (Tmax = 2–3 hours)
MetabolismExtensive hepatic
Onset of action1–1.5 hours
ExcretionBiliary (95%), renal (5%)
Identifiers
  • 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.046.770 Edit this at Wikidata
Chemical and physical data
FormulaC27H33N3O6S
Molar mass527.64 g·mol−1
3D model (JSmol)
SMILES
  • O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)CCN4C(=O)c3c(ccc(OC)c3)C(C4=O)(C)C
InChI
  • InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33) checkY
  • Key:LLJFMFZYVVLQKT-UHFFFAOYSA-N checkY
  

Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic medication in the sulfonylurea class. It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).

Contraindications[]

  • Allergy to sulfonylureas or sulfonamides
  • Diabetes mellitus type 1
  • Diabetic ketoacidosis
  • Patients that underwent removal of the pancreas
  • Acute porphyria
  • Severe liver disease accompanying with liver insufficiency
  • Several conditions (e.g., infectious diseases or major surgical intervention), when insulin administration is required
  • Pregnancy or breastfeeding[1]

Pharmacokinetics[]

Gliquidone is fully metabolized by the liver. Its metabolites are excreted virtually completely with bile (even with long-term administration), thus allowing the use of medication in diabetic patients suffering from kidney disease and diabetic nephropathy.[1]

References[]

  1. ^ a b "Glurenorm (gliquidone) 30 mg Tablets, for Oral Use. Full Prescribing Information". Russian State Register of Medicinal Products (in Russian). Boehringer Ingelheim. Archived from the original on 14 August 2016. Retrieved 12 July 2016.
Retrieved from ""